In individuals without diabetes, a decline in endogenous insulin secretion (from β cells) and a rise in glucagon secretion (from α cells) limit hypoglycemia when blood glucose levels decline to approximately 3.5 mmol/L. The gene discussed is GCG; the disease is Hypoglycemia.